Valiant Laboratories lists at Rs 162, a 16% premium to IPO price
Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol
Stay updated with breaking news from Valiant Advanced Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Valiant Laboratories is an active pharmaceutical ingredient and bulk drug manufacturing company with focus on manufacturing of paracetamol
Valiant Laboratories IPO | The company will finalise the basis of allotment of shares by the end of October 5 and the shares will be credited to the demat accounts of eligible investors by October 6. Trading will begin on October 9
Valiant Laboratories IPO | The public issue will be closing on October 3.
Valiant Laboratories IPO | The pharmaceutical ingredient manufacturing company aims to raise Rs 152.46 crore via maiden public issue of 1.09 crore equity shares comprising only a fresh issue portion.
Valiant Laboratories IPO |that focuses on manufacturing Paracetamol intends to raise Rs 152.46 crore via public issue at the upper price band, which comprises only a fresh issue component.